242 related articles for article (PubMed ID: 37524486)
1. Progress in the development of kinase inhibitors for treating asthma and COPD.
McClean N; Hasday JD; Shapiro P
Adv Pharmacol; 2023; 98():145-178. PubMed ID: 37524486
[TBL] [Abstract][Full Text] [Related]
2. Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease.
Barnes PJ
Pharmacol Rev; 2016 Jul; 68(3):788-815. PubMed ID: 27363440
[TBL] [Abstract][Full Text] [Related]
3. Muscarinic receptors on airway mesenchymal cells: novel findings for an ancient target.
Meurs H; Dekkers BG; Maarsingh H; Halayko AJ; Zaagsma J; Gosens R
Pulm Pharmacol Ther; 2013 Feb; 26(1):145-55. PubMed ID: 22842340
[TBL] [Abstract][Full Text] [Related]
4. Distinct PKA and Epac compartmentalization in airway function and plasticity.
Dekkers BG; Racké K; Schmidt M
Pharmacol Ther; 2013 Feb; 137(2):248-65. PubMed ID: 23089371
[TBL] [Abstract][Full Text] [Related]
5. Treatment of airway mucus hypersecretion.
Rogers DF; Barnes PJ
Ann Med; 2006; 38(2):116-25. PubMed ID: 16581697
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB Signaling in Chronic Inflammatory Airway Disease.
Schuliga M
Biomolecules; 2015 Jun; 5(3):1266-83. PubMed ID: 26131974
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic receptor signaling in the pathophysiology of asthma and COPD.
Gosens R; Zaagsma J; Meurs H; Halayko AJ
Respir Res; 2006 May; 7(1):73. PubMed ID: 16684353
[TBL] [Abstract][Full Text] [Related]
8. [The effects of NOX4 and TGF-βinvolved in airway remodeling of Chronic Obstructive Pulmonary Disease].
Chen J; Cui JD; Guo XT; Liu XY; Zhang H
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Jun; 33(6):481-487. PubMed ID: 29931894
[TBL] [Abstract][Full Text] [Related]
9. Regulation of airway inflammation and remodeling by muscarinic receptors: perspectives on anticholinergic therapy in asthma and COPD.
Kistemaker LE; Oenema TA; Meurs H; Gosens R
Life Sci; 2012 Nov; 91(21-22):1126-33. PubMed ID: 22406302
[TBL] [Abstract][Full Text] [Related]
10. Necroptosis Signaling Promotes Inflammation, Airway Remodeling, and Emphysema in Chronic Obstructive Pulmonary Disease.
Lu Z; Van Eeckhoutte HP; Liu G; Nair PM; Jones B; Gillis CM; Nalkurthi BC; Verhamme F; Buyle-Huybrecht T; Vandenabeele P; Vanden Berghe T; Brusselle GG; Horvat JC; Murphy JM; Wark PA; Bracke KR; Fricker M; Hansbro PM
Am J Respir Crit Care Med; 2021 Sep; 204(6):667-681. PubMed ID: 34133911
[No Abstract] [Full Text] [Related]
11. Vascular Biomarkers in Asthma and COPD.
Bakakos P; Patentalakis G; Papi A
Curr Top Med Chem; 2016; 16(14):1599-609. PubMed ID: 26420364
[TBL] [Abstract][Full Text] [Related]
12. New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways.
Lai H; Rogers DF
J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):219-31. PubMed ID: 20695774
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic perspectives in vascular remodeling in asthma and chronic obstructive pulmonary disease.
Olivieri D; Chetta A
Chem Immunol Allergy; 2014; 99():216-25. PubMed ID: 24217612
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis signal-regulating kinase 1 inhibition attenuates human airway smooth muscle growth and migration in chronic obstructive pulmonary disease.
Eapen MS; Kota A; Vindin H; McAlinden KD; Xenaki D; Oliver BG; Deshpande DA; Sohal SS; Sharma P
Clin Sci (Lond); 2018 Jul; 132(14):1615-1627. PubMed ID: 30006481
[TBL] [Abstract][Full Text] [Related]
15. Role of p38 Mitogen-Activated Protein Kinase in Asthma and COPD: Pathogenic Aspects and Potential Targeted Therapies.
Pelaia C; Vatrella A; Gallelli L; Lombardo N; Sciacqua A; Savino R; Pelaia G
Drug Des Devel Ther; 2021; 15():1275-1284. PubMed ID: 33790539
[TBL] [Abstract][Full Text] [Related]
16. Small molecule inhibitors of cell signaling: novel future therapeutics for asthma and chronic obstructive pulmonary diseases.
Blease K; Raymon HK
Curr Opin Investig Drugs; 2003 May; 4(5):544-51. PubMed ID: 12833647
[TBL] [Abstract][Full Text] [Related]
17. Rho kinase as a therapeutic target in the treatment of asthma and chronic obstructive pulmonary disease.
Fernandes LB; Henry PJ; Goldie RG
Ther Adv Respir Dis; 2007 Oct; 1(1):25-33. PubMed ID: 19124345
[TBL] [Abstract][Full Text] [Related]
18. Different anti-remodeling effect of nilotinib and fluticasone in a chronic asthma model.
Kang HS; Rhee CK; Lee HY; Yoon HK; Kwon SS; Lee SY
Korean J Intern Med; 2016 Nov; 31(6):1150-1158. PubMed ID: 27764539
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of TROP2 in airway basal cells potentially contributes to airway remodeling in chronic obstructive pulmonary disease.
Liu Q; Li H; Wang Q; Zhang Y; Wang W; Dou S; Xiao W
Respir Res; 2016 Nov; 17(1):159. PubMed ID: 27887617
[TBL] [Abstract][Full Text] [Related]
20. Acetylcholine beyond bronchoconstriction: roles in inflammation and remodeling.
Kistemaker LE; Gosens R
Trends Pharmacol Sci; 2015 Mar; 36(3):164-71. PubMed ID: 25511176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
